Madame Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	308.62	80.19	34.34	252.69	41.26	99.83
Short-Term Investments	1.63	0.43	0.42	0.65	11.13	-
Cash & Short-Term Investments	310.25	80.62	34.76	253.34	52.39	99.83
Cash Growth	1384.59%	131.96%	-86.28%	383.56%	-47.52%	-60.71%
Accounts Receivable	172	284.08	293.04	261.71	310.9	231.06
Other Receivables	51.24	57.6	42.64	49.17	35.98	-
Receivables	223.24	341.68	335.68	310.87	346.87	231.06
Inventory	70.19	142.02	237.64	280.56	361.82	245.41
Prepaid Expenses	16.45	8.11	8.77	7.44	12.71	-
Other Current Assets	32.86	12.93	17.86	29.81	66.65	64.73
Total Current Assets	652.99	585.35	634.7	882.03	840.44	641.03
Property, Plant & Equipment	589.64	675.01	943.3	1,015	624.97	563.43
Goodwill	327.72	241.08	241.08	429.05	77.47	103.49
Other Intangible Assets	107.2	62.49	67.83	73.34	5.33	118.35
Long-Term Deferred Tax Assets	-	0.53	1.67	7.25	5.58	5.58
Other Long-Term Assets	130.31	50.8	149.98	49.89	30.96	63.7
Total Assets	1,808	1,615	2,039	2,457	1,585	1,496
Accounts Payable	159.63	282.28	242.78	185.02	209.32	177.83
Accrued Expenses	26.56	70.34	82.52	47.29	78.1	4.86
Short-Term Debt	268.51	159.79	161.75	196.61	138.19	108.46
Current Portion of Long-Term Debt	124.97	239.46	363.51	61.86	31.55	11.91
Current Portion of Leases	11.85	15.98	18.67	24.95	22.28	20.72
Current Income Taxes Payable	-	-	-	-	-	2.02
Other Current Liabilities	74.95	57.7	66.44	63.73	64.74	50.3
Total Current Liabilities	666.47	825.54	935.67	579.47	544.18	376.11
Long-Term Debt	-	40.9	102.81	456.24	97.27	8.82
Long-Term Leases	158.36	158.02	172.92	182.25	33.88	52.9
Pension & Post-Retirement Benefits	18.14	29.42	25.07	23.46	14.97	15.77
Long-Term Deferred Tax Liabilities	33.13	20.3	23.02	24	5.83	28.54
Other Long-Term Liabilities	2.17	2.29	1.79	0.01	2.61	9.7
Total Liabilities	878.27	1,076	1,261	1,265	698.73	491.83
Common Stock	2,020	1,717	1,538	1,538	2,120	1,913
Additional Paid-In Capital	-	-	59.43	59.43	-	-
Retained Earnings	-905.73	-1,137	-810.61	-403.84	-1,028	-876.23
Comprehensive Income & Other	-229.05	-84.86	-49.19	-49.19	-177.68	-33.06
Total Common Equity	884.75	495.51	737.83	1,145	914.1	1,003
Minority Interest	44.85	43.3	39.46	46.75	-28.08	0.35
Shareholders' Equity	929.59	538.8	777.28	1,191	886.03	1,004
Total Liabilities & Equity	1,808	1,615	2,039	2,457	1,585	1,496
Total Debt	563.69	614.14	819.66	921.92	323.17	202.81
Net Cash (Debt)	-253.44	-533.52	-784.91	-668.57	-270.78	-102.98
Net Cash Per Share	-0.07	-0.17	-0.26	-0.22	-0.14	-0.05
Filing Date Shares Outstanding	4,039	3,434	3,076	3,076	2,120	1,913
Total Common Shares Outstanding	4,039	3,434	3,076	3,076	2,120	1,913
Working Capital	-13.48	-240.19	-300.97	302.56	296.27	264.92
Book Value Per Share	0.22	0.14	0.24	0.37	0.43	0.52
Tangible Book Value	449.83	191.94	428.92	642.21	831.3	781.56
Tangible Book Value Per Share	0.11	0.06	0.14	0.21	0.39	0.41
Land	-	94.65	93.68	93.68	68.66	77.83
Buildings	-	365.39	464.49	450.88	164.24	213.18
Machinery	-	541.77	861.78	908.65	640.66	642.21
Construction In Progress	-	4.08	7.91	12.97	150.21	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.